Portuguese 
Spanish 
New Brazilian Reactor Will Enable National Production of Essential Radiopharmaceuticals for Treatment of Serious Diseases, Reducing External Dependence
Brazil is advancing in the construction of the Brazilian Multipurpose Reactor (RMB), located in Iperó, in the interior of São Paulo, a project that promises to revolutionize nuclear medicine in the country. According to information from Agência Brasil, the goal is to make the country independent in the production of essential radioisotopes for the manufacture of radiopharmaceuticals, used in the diagnosis and treatment of serious diseases, such as cancer.
Currently, according to data released by Amazul, the country depends on the import of these supplies from countries such as Argentina, the Netherlands, and South Africa. This dependence creates risks of supply shortages and high costs for the Unified Health System (SUS).
Benefits for SUS and the Brazilian Population
According to the portal O Cafezinho, the RMB will enable SUS to offer innovative treatments with greater efficiency and lower costs, directly benefiting millions of Brazilians. As a result, the public system will have the capacity to perform more accurate exams and more effective treatments, significantly increasing the quality and life expectancy of patients.
-
Potential Starlink Rival: Company Tests 60-Meter Balloon to Deliver 5G Internet Without Satellites, Prepares for Unprecedented Mission in Japan
-
Android Phones Can Detect Earthquakes Before You Feel Them: How Accelerometers in Billions of Devices Confirmed Two Strong Quakes in Venezuela and Warned Residents Seconds in Advance
-
Scientists Warn WHO: Cat-Linked Parasite Infects One-Third of Global Population, Poses Risks to Vision, Pregnancy, and Neurological Health
-
NASA Rover Discovers Organic Carbon in Ancient River Region on Mars, Raising Hopes for Past Life
Strategic Investment in Brazilian Science
The Ministry of Science and Technology highlighted that, in addition to direct benefits to public health, the RMB will represent a milestone in the country’s nuclear research, boosting technological innovation and strengthening the science and technology sector in Brazil.
According to information from Agência Brasil, the completion of the works is expected to occur by 2030, positioning Brazil as one of the few countries with its own technology for autonomous production of essential radiopharmaceuticals.
What Are Radiopharmaceuticals and What Is the Importance of the MB Reactor?
Radiopharmaceuticals are radioactive medications used in diagnostic exams such as CT scans and in the treatment of diseases such as cancer, heart problems, and neurological issues. The construction of the RMB signifies a revolution in national nuclear medicine, allowing Brazil to stop depending on foreign suppliers and develop these substances locally.
This strategic advance not only strengthens national autonomy in health but also promotes the country’s energy and technological security.
